NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
06/26/2025
Back to search
Official data from USPTO
HEMOPHILIA FORWARD
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
HEMOPHILIA FORWARD
ST13
US500000087829643Class
35, 42, 44
Filing
87829643
Registration
5741234
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
36
Latest update
06/27/2025
Trademark type
Word
Nice classes
35, 42, 44
Filing date
03/12/2018
Registration date
04/30/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/26/2025
Last transaction
06/27/2025
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
04/17/2018
First use in commerce
04/24/2018
Drawing code
4
Owner type
03
Owner location
Philadelphia, PA
Examiner
MORENO, PAUL
Current location
Historical data usage
Holders and representatives
Holders
Spark Therapeutics, Inc.
Representatives
Susan A. Smith Ballard Spahr LLP
Technical classification
Nice Classes
Class 35Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Promoting public awareness of hemophiliagene therapy researchgenetic testing for medical purposesmedical information in relation to community stories and resources
Class 42
Providing information and a website featuring information about gene therapy research in relation to community stories and resources
Class 44
Providing information and a website featuring information about diagnosis and treatment of hemophiliagenetic testing for medical purposesmedical information in relation to community stories and resources
Publications
History of USPTO decisions and trademark events.
36 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
06/26/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/26/2025
E815
TEAS SECTION 8 & 15 RECEIVED
02/28/2025
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
04/30/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
04/30/2019
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
03/26/2019
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
03/25/2019
SUPC
STATEMENT OF USE PROCESSING COMPLETE
03/20/2019
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
03/15/2019
IUAF
USE AMENDMENT FILED
02/25/2019
EISU
TEAS STATEMENT OF USE RECEIVED
02/25/2019
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
02/19/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/25/2018
PUBO
PUBLISHED FOR OPPOSITION
12/25/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/05/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/14/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/13/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/13/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/13/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/05/2018
GNRT
NON-FINAL ACTION E-MAILED
11/05/2018
CNRT
NON-FINAL ACTION WRITTEN
11/05/2018
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
10/05/2018
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
09/11/2018
ALIE
ASSIGNED TO LIE
08/23/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/14/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/14/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/14/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/14/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/12/2018
GNRT
NON-FINAL ACTION E-MAILED
06/12/2018
CNRT
NON-FINAL ACTION WRITTEN
06/12/2018
DOCK
ASSIGNED TO EXAMINER
06/12/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/17/2018
NWAP
NEW APPLICATION ENTERED
03/15/2018
Continuous trademark protection
Get notified about every new filing that threatens HEMOPHILIA FORWARD or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.